tiprankstipranks
Corcept Therapeutics (CORT)
NASDAQ:CORT
US Market
CORT
Corcept Therapeutics
RESEARCH TOOLSreports
Want to see CORT full AI Analyst Report?

Corcept Therapeutics (CORT) Stock Forecast & Price Target

1,310 Followers
See the Price Targets and Ratings of:

CORT Analyst Ratings

Strong Buy
4Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Corcept
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CORT Stock 12 Month Forecast

Average Price Target

$97.50
▲(111.22% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Corcept Therapeutics in the last 3 months. The average price target is $97.50 with a high forecast of $135.00 and a low forecast of $72.00. The average price target represents a 111.22% change from the last price of $46.16.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"33":"$33","136":"$136","58.75":"$58.8","84.5":"$84.5","110.25":"$110.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":135,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$135.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":97.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$97.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":72,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$72.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[33,58.75,84.5,110.25,136],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,88.48,92.05846153846154,95.63692307692308,99.21538461538462,102.79384615384616,106.3723076923077,109.95076923076923,113.52923076923076,117.1076923076923,120.68615384615384,124.26461538461538,127.84307692307692,131.42153846153846,{"y":135,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,88.48,89.17384615384616,89.86769230769231,90.56153846153846,91.25538461538461,91.94923076923077,92.64307692307693,93.33692307692309,94.03076923076924,94.72461538461539,95.41846153846154,96.1123076923077,96.80615384615385,{"y":97.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,88.48,87.21230769230769,85.94461538461539,84.67692307692307,83.40923076923077,82.14153846153846,80.87384615384616,79.60615384615384,78.33846153846154,77.07076923076923,75.80307692307693,74.53538461538461,73.26769230769231,{"y":72,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":69.31,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.38,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.25,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.47,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.78,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.8,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.71,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.97,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.98,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.42,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.44,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.48,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$135.00Average Price Target$97.50Lowest Price Target$72.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on CORT
Edward Nash
Canaccord Genuity
Canaccord Genuity
$135
Buy
192.46%
Upside
Reiterated
07/09/26
Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Corcept Therapeutics (CORT)
H.C. Wainwright Analyst forecast on CORT
Swayampakula Ramakanth
H.C. Wainwright
H.C. Wainwright
$95
Buy
105.81%
Upside
Reiterated
06/02/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), Corcept Therapeutics (NASDAQ: CORT) and Taysha Gene Therapies (NASDAQ: TSHA)
Piper Sandler Analyst forecast on CORT
David Amsellem
Piper Sandler
Piper Sandler
$88
Buy
90.64%
Upside
Reiterated
06/01/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
UBS Analyst forecast on CORT
Ashwani Verma
UBS
UBS
$72
Buy
55.98%
Upside
Upgraded
05/13/26
Corcept Therapeutics upgraded to Buy from Neutral at UBSCorcept Therapeutics upgraded to Buy from Neutral at UBS
Wolfe Research Analyst forecast on CORT
Kalpit Patel
Wolfe Research
Wolfe Research
―
Hold
―
Upgraded
03/26/26
Corcept Therapeutics upgraded to Peer Perform from Underperform at Wolfe ResearchCorcept Therapeutics upgraded to Peer Perform from Underperform at Wolfe Research
Truist Financial Analyst forecast on CORT
Joon Lee
Truist Financial
Truist Financial
―
Buy
―
Reiterated
03/02/26
Wall Street Analysts Are Bullish on Top NA Picks
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on CORT
Edward Nash
Canaccord Genuity
Canaccord Genuity
$135
Buy
192.46%
Upside
Reiterated
07/09/26
Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Corcept Therapeutics (CORT)
H.C. Wainwright Analyst forecast on CORT
Swayampakula Ramakanth
H.C. Wainwright
H.C. Wainwright
$95
Buy
105.81%
Upside
Reiterated
06/02/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), Corcept Therapeutics (NASDAQ: CORT) and Taysha Gene Therapies (NASDAQ: TSHA)
Piper Sandler Analyst forecast on CORT
David Amsellem
Piper Sandler
Piper Sandler
$88
Buy
90.64%
Upside
Reiterated
06/01/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
UBS Analyst forecast on CORT
Ashwani Verma
UBS
UBS
$72
Buy
55.98%
Upside
Upgraded
05/13/26
Corcept Therapeutics upgraded to Buy from Neutral at UBSCorcept Therapeutics upgraded to Buy from Neutral at UBS
Wolfe Research Analyst forecast on CORT
Kalpit Patel
Wolfe Research
Wolfe Research
―
Hold
―
Upgraded
03/26/26
Corcept Therapeutics upgraded to Peer Perform from Underperform at Wolfe ResearchCorcept Therapeutics upgraded to Peer Perform from Underperform at Wolfe Research
Truist Financial Analyst forecast on CORT
Joon Lee
Truist Financial
Truist Financial
―
Buy
―
Reiterated
03/02/26
Wall Street Analysts Are Bullish on Top NA Picks
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
KURAKura Oncology
CSTLCastle Biosciences
VKTXViking Therapeutics
ATECAlphatec Holdings
TRVITrevi Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Corcept Therapeutics

3 Months
Joon LeeTruist Financial
Success Rate
16/22 ratings generated profit
73%
Average Return
+10.26%
Copying Joon Lee's trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +10.26% per trade.
1 Year
David AmsellemPiper Sandler
Success Rate
22/26 ratings generated profit
85%
Average Return
+57.18%
Copying David Amsellem's trades and holding each position for 1 Year would result in 84.62% of your transactions generating a profit, with an average return of +57.18% per trade.
2 Years
David AmsellemPiper Sandler
Success Rate
26/26 ratings generated profit
100%
Average Return
+93.75%
Copying David Amsellem's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +93.75% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CORT Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
16
14
11
5
3
Buy
5
2
5
5
6
Hold
1
1
1
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
17
17
10
9
In the current month, CORT has received 9 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CORT average Analyst price target in the past 3 months is 97.50.
Each month's total comprises the sum of three months' worth of ratings.

CORT Financial Forecast

CORT Earnings Forecast

Next quarter’s earnings estimate for CORT is $0.01 with a range of -$0.09 to $0.06. The previous quarter’s EPS was -$0.30. CORT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year CORT has Performed in-line its overall industry.
Next quarter’s earnings estimate for CORT is $0.01 with a range of -$0.09 to $0.06. The previous quarter’s EPS was -$0.30. CORT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year CORT has Performed in-line its overall industry.

CORT Sales Forecast

Next quarter’s sales forecast for CORT is $219.13M with a range of $210.00M to $225.00M. The previous quarter’s sales results were $164.90M. CORT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year CORT has Performed in-line its overall industry.
Next quarter’s sales forecast for CORT is $219.13M with a range of $210.00M to $225.00M. The previous quarter’s sales results were $164.90M. CORT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year CORT has Performed in-line its overall industry.

CORT Stock Forecast FAQ

What is CORT’s average 12-month price target, according to analysts?
Based on analyst ratings, Corcept Therapeutics’s 12-month average price target is 97.50.
    What is CORT’s upside potential, based on the analysts’ average price target?
    Corcept Therapeutics has 111.22% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CORT a Buy, Sell or Hold?
          Corcept Therapeutics has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Corcept Therapeutics’s price target?
            The average price target for Corcept Therapeutics is 97.50. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $135.00 ,the lowest forecast is $72.00. The average price target represents 111.22% Increase from the current price of $46.16.
              What do analysts say about Corcept Therapeutics?
              Corcept Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of CORT?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.